Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
NCT02670408 · View on ClinicalTrials.gov ↗
Study Summary
Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.
Conditions Studied
Interventions
- PROCEDURE Endomyocardial biopsy
Study Locations (13)
Other
- Cardiac Transplantation Laboratory, The Victor Chang Cardiac Research Institute — Darlinghurst
- Department of Cardiac Surgery, Medical University of Vienna — Vienna
- Institute for Clinical and Experimental Medicine - IKEM — Prague
- Service de Néphrologie-Dialyse Adultes , Hôpital Necker-Enfants Malades — Paris
- Heart Failure and Heart Transplant Unit, University of Bologna — Bologna
- Advanced Heart Failure Transplant Unit — A Coruña
California
- UCLA Medical Centre — Los Angeles
- Cedars-Sinai Heart Institute — Los Angeles
Alberta
- Alberta Transplant Applied Genomics Center, University of Alberta — Edmonton
- Division of Cardiology, University of Alberta — Edmonton
Texas
- Annette C. and Harold C. Simmons Transplant Institute, BaylorScott&White Research Institute — Dallas
Utah
- Cardiovascular Medicine, University of Utah Health — Salt Lake City
Virginia
- Virginia Commonwealth University, Division of Cardiology — Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2016-01 |
| Est. Completion | 2027-07 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02670408
The ClinicalTrials.gov registry entry for NCT02670408 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alberta, which has 135 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Cardiac Transplant Disorder appearing as the primary indexed condition, and to 1 intervention — of which Endomyocardial biopsy is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02670408 reports 13 study locations spanning 6 distinct geographic areas — top geographies include Other, California, Alberta. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02670408 about?
NCT02670408 is a clinical study titled "Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation". Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.
What is the current status of trial NCT02670408?
This trial is currently recruiting. The enrollment target is 900 participants. The study started on 2016-01. Estimated completion is 2027-07.
What conditions does trial NCT02670408 study?
This clinical trial studies the following conditions: Cardiac Transplant Disorder. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT02670408?
The interventions under investigation include: Endomyocardial biopsy (PROCEDURE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT02670408?
This trial is sponsored by University of Alberta, which has 135 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02670408 being conducted?
This trial has 13 study locations across California, Texas, Utah, Virginia, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.